BPC-157 is a 15-residue, 1419.53 g/mol pentadecapeptide whose mechanistic literature centres on local angiogenic signalling, Hsieh and colleagues (J Mol Med, 2017) reported upregulation and internalisation of VEGFR2 in human endothelial cells, and Chang and colleagues (J Appl Physiol, 2011) reported increased FAK and paxillin phosphorylation with greater outgrowth and migration in cultured rat tendon fibroblasts
A systematic review covering 36 studies from 1993 to 2024 (PMC 12313605) confirmed healing benefits across gut, musculoskeletal, and neurological tissue
Mouse models created to study the pathophysiology of Type 2 diabetes
Regulation of Inflammatory Response: BPC-157 balances levels of pro-inflammatory and anti-inflammatory factors, reducing inflammation while preventing excessive immune reactions
NAD+ refers to nicotinamide adenine dinucleotide, a vitamin B3 derivative